Atabecestat (JNJ-54861911) is a potent brain-osmotic and has oral activity beta-position amyloid precursor protein lyase 1 (BACE1 inhibitors that strongly reduce the expression of Abeta protein in cerebrospinal fluid. Atabecestat (JNJ-54861911) is tolerant and has sustained pharmacokinetic (PK) and pharmacodynamic (PD) profiles. Atabecestat (JNJ-54861911) has the potential to be used in the study of Alzheimers disease.
Molecular Weight:
367.4
Purity:
>99.0%
CAS Number:
[1200493-78-2]
Formula:
C18H14FN5OS
Target:
BACE
* VAT and and shipping costs not included. Errors and price changes excepted